Retrograde ejaculation is the consequence of surgical procedures or is associated with the use of various neuroleptic and nonneuroleptic drugs
+(3). These effectors are presumed to alter the sympathetic tonus of the bladder or urethral sphincter, allowing semen to pass retrogradely into the bladder during ejaculation. To date, all drugs reported to induce retrograde ejaculation share the capacity to significantly antagonize the α
1-adrenergic receptor
+(3). We assume that risperidone, a potent α
1-adrenergic receptor antagonist, induces retrograde ejaculation by means of a similar mechanism. The initial rapid escalation of the patient’s dose by 1 mg/day might have also contributed to the emergence of retrograde ejaculation, as described in other cases of neuroleptic-induced retrograde ejaculation
+(4). The incidence and clinical implications of risperidone-induced retrograde ejaculation and its effect on patient compliance merit further investigation.